Literature DB >> 15517136

[Dyspnea of undetermined origin. Fibrosing alveolitis (FA) in seropositive rheumatoid arthritis (RA)].

T Schlossbauer1, C Becker-Gaab, M Reiser.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15517136     DOI: 10.1007/s00117-004-1129-2

Source DB:  PubMed          Journal:  Radiologe        ISSN: 0033-832X            Impact factor:   0.635


× No keyword cloud information.
  6 in total

Review 1.  American Thoracic Society. Idiopathic pulmonary fibrosis: diagnosis and treatment. International consensus statement. American Thoracic Society (ATS), and the European Respiratory Society (ERS).

Authors: 
Journal:  Am J Respir Crit Care Med       Date:  2000-02       Impact factor: 21.405

Review 2.  Idiopathic pulmonary fibrosis: clinical relevance of pathologic classification.

Authors:  A L Katzenstein; J L Myers
Journal:  Am J Respir Crit Care Med       Date:  1998-04       Impact factor: 21.405

Review 3.  Potential pathogenesis and clinical aspects of pulmonary fibrosis associated with rheumatoid arthritis.

Authors:  B R Gochuico
Journal:  Am J Med Sci       Date:  2001-01       Impact factor: 2.378

4.  Fibrosing alveolitis in patients with rheumatoid arthritis as assessed by high resolution computed tomography, chest radiography, and pulmonary function tests.

Authors:  J K Dawson; H E Fewins; J Desmond; M P Lynch; D R Graham
Journal:  Thorax       Date:  2001-08       Impact factor: 9.139

Review 5.  [Pleural and pulmonary changes within the scope of rheumatoid arthritis].

Authors:  A A Bankier; D Fleischmann; H P Kiener; M N Wiesmayr; C J Herold
Journal:  Radiologe       Date:  1996-08       Impact factor: 0.635

Review 6.  Pulmonary fibrosis in rheumatoid arthritis: a review of clinical features and therapy.

Authors:  R A Roschmann; R J Rothenberg
Journal:  Semin Arthritis Rheum       Date:  1987-02       Impact factor: 5.532

  6 in total
  1 in total

Review 1.  [Pulmonary manifestations in rheumatic systemic diseases].

Authors:  T Schlossbauer; C Becker-Gaab; R Eibel
Journal:  Radiologe       Date:  2005-07       Impact factor: 0.635

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.